Reyataz (HIV)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
3 Disease Overview 10
3.1 Etiology and Pathophysiology 10
3.1.1 Etiology 10
3.1.2 Pathophysiology 13
3.1.3 Prognosis 13
3.1.4 Quality of Life 14
3.2 Symptoms 14
3.2.1 Primary or Acute Infection 14
3.2.2 Chronic Infection 14
3.2.3 Advanced Infection/AIDS 15
4 Disease Management 16
4.1 Treatment Overview 16
5 Competitive Assessment 20
5.1 Overview 20
5.2 Strategic Competitor Assessment 20
6 Reyataz (atazanavir) 23
6.1 Overview 23
6.2 Efficacy 24
6.3 Safety 25
6.4 SWOT Analysis 25
6.5 Forecast 27
7 Appendix 28
7.1 Bibliography 28
7.2 Abbreviations 30
7.3 Methodology 32
7.4 Forecasting Methodology 32
7.4.1 HIV Prevalence 32
7.4.2 Percent Drug-Treated Patients 32
7.4.3 General Pricing Assumptions 33
7.4.4 Individual Drug Assumptions 34
7.4.5 Generic Erosion 34
7.5 Physicians and Specialists Included in this Study 35
7.5.1 Survery of Prescribing Physicians 36
7.6 About the Authors 36
7.6.1 Authors 36
7.6.2 Global Head of Healthcare 37
7.7 About GlobalData 38
7.8 Contact Us 38
7.9 Disclaimer 38